Current Neurology and Neuroscience Reports

, Volume 5, Issue 2, pp 137–139 | Cite as

Ropinirole in the treatment of restless legs syndrome

  • Michael Thorpy
Clinical Trials Report

Keywords

Ropinirole Large Placebo Effect Medical Outcome Study Sleep Scale Ropinirole Group Impaired Daytime Functioning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Phillips B, Young T, Finn L, et al.: Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000, 160:2137–2141.PubMedCrossRefGoogle Scholar
  2. 2.
    Montplaisir J, Boucher S, Poirier G, et al.: Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004, 75:92–97.Google Scholar
  3. 3.
    The International Restless Legs Syndrome Study Group: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121–132.CrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • Michael Thorpy

There are no affiliations available

Personalised recommendations